Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device
- Conditions
- Sleep Disorder
- Interventions
- Device: CPC M1
- Registration Number
- NCT01234077
- Lead Sponsor
- National Jewish Health
- Brief Summary
Research study that will test a portable device (CPC M1) that records: body movement; heart activity (ECG; snoring; and body position during sleep. The Food and Drug Administration (FDA) has not approved this device for use except in a research setting.
The purposes of this study are to: a) determine if the ECG data collected using the CPC M1 device is at least as good as the ECG data collected during a diagnostic, in-lab polysomnogram (PSG) (or sleep study) and b) determine if in-home monitoring with the device will provide similar results compared to an in-lab PSG.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Adults (males and females) 18 to 70 years of age with a suspected sleep disorder.
- Subjects or legal guardians are able to verbalize an understanding of the consent form, provide written informed consent, and verbalize willingness to complete study procedures.
- Adequate dexterity to apply and remove the CPC M1 device.
- Patients with atrial fibrillation and ventricular tachycardia.
- Patients with an inability to apply the CPC M1 device.
- Pregnancy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ECG recording CPC M1 In-laboratory vs. in-home recordings
- Primary Outcome Measures
Name Time Method Sensitivity and specificity of an electrocardiogram-based method to predict the presence of a sleep disorder. 6 months What is the sensitivity/specificity of the ECG-based method recorded in-lab vs. in the home.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
National Jewish Health
🇺🇸Denver, Colorado, United States